Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Study: Give more statins, save more money
Fierce Pharma
Tuesday, September 28, 2010 - 3:26pm
tags:
statins, CRP, AstraZeneca, Crestor
Bayer Pushes Its Luck With Birth Control Pill That Promotes Healthy Pregnancy
BNET Pharma
Tuesday, September 28, 2010 - 3:24pm
tags:
Bayer, birth control pill, Beyaz
Don’t Be Suckered By Eli Lilly’s Cheap Stock
Forbes
Tuesday, September 28, 2010 - 3:22pm
tags:
Eli Lilly
Palatin cuts half its workforce, discovery R&D
Fierce Biotech
Tuesday, September 28, 2010 - 12:34pm
tags:
Palatin, layoffs
FDA: New Rules To Report Safety Info From Trials
Pharmalot
Tuesday, September 28, 2010 - 11:55am
tags:
drug safety, FDA, clinical trials
The most (and least) efficient Big Pharma companies
Fierce Pharma
Tuesday, September 28, 2010 - 11:54am
tags:
Roche, Bristol-Myers Squibb, Eli Lilly, JNJ, GSK, AstraZeneca, Novartis, Pfizer, Abbott Laboratories, Sanofi, Merck, Bayer
Sanofi’s Patents on Cancer Drug Taxotere Invalidated
Bloomberg
Tuesday, September 28, 2010 - 11:52am
tags:
patents, Taxotere, Sanofi, cancer
Pfizer Fined For Price Fixing In Indonesia
Pharmalot
Tuesday, September 28, 2010 - 11:22am
tags:
Indonesia, price fixing, Pfizer
Cypress Bioscience board rejects new Ramius bid
Yahoo/AP
Tuesday, September 28, 2010 - 11:21am
tags:
Ramius, Cypress Bioscience, M&A
A.M. Vitals: U.S. Appeals Court Hears Stem Cell Arguments
WSJ Online
Tuesday, September 28, 2010 - 10:50am
tags:
stem cells, appeals
Bristol-Myers buy of ZymoGenetics clears hurdle
Marketwatch
Tuesday, September 28, 2010 - 10:47am
tags:
Bristol-Myers Squibb, M&A, ZymoGenetics
Here’s What Medicare Will Ask About Provenge
Pharmalot
Tuesday, September 28, 2010 - 7:47am
tags:
Medicare, Dendreon, Provenge, prostate cancer
King Pharmaceuticals: Looking Ahead to September 2010 Quarterly Results
Seeking Alpha
Tuesday, September 28, 2010 - 7:46am
tags:
earnings, King
Endo Pharma to Buy Qualitest for $1.2B
TheStreet.com
Tuesday, September 28, 2010 - 7:45am
tags:
generics, Endo, Qualitest, M&A
Now That's What I Call a Drug That Works (Seattle Genetics)
Motley Fool
Tuesday, September 28, 2010 - 7:45am
tags:
Seattle Genetics, brentuximab vedotin, Hodgkin's lymphoma
Pfizer Inc. (NYSE:PFE) – Q3 2010 Earnings Preview
iStockAnalyst
Monday, September 27, 2010 - 10:06pm
tags:
Pfizer, earnings
Will Johnson & Johnson Blow It Next Quarter?
Motley Fool
Monday, September 27, 2010 - 10:04pm
tags:
JNJ, earnings
Actelion's Experimental Drug for Brain Hemorrhage Fails to Meet Study Goal
Bloomberg
Monday, September 27, 2010 - 5:46pm
tags:
Actelion, brain hemorrhage, clazosentan
Allergan, Hologic Pass FDA Checkpoints
Forbes
Monday, September 27, 2010 - 5:44pm
tags:
Hologic, FDA, Allergan, Ozurdex
Pfizer halts study of Sutent for prostate cancer
Marketwatch
Monday, September 27, 2010 - 5:42pm
tags:
Sutent, prostate cancer, Pfizer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.